Using prenatal magnetic resonance imaging, a group of MedUni Vienna researchers examined the placentas and fetuses of women who tested positive for SARS-CoV-2 during pregnancy. Their research results demonstrate that the ...
Jan 23, 2023
0
67
High levels of mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months. Omicron infection generates durable mucosal antibodies, reducing the risk of re-infection. These are the ...
Jan 16, 2023
0
37
Researchers at the AIDS Institute, Department of Microbiology, School of Clinical Medicine, and the State Key Laboratory of Emerging Infectious Diseases, LKS Faculty of Medicine of The University of Hong Kong (HKUMed) reveals ...
Jan 4, 2023
0
80
COVID-19 vaccinations that combine two or more distinct variants of the SARS-CoV-2 virus could offer protection against both current and future "variants of concern," say scientists at the University of Cambridge and Medical ...
Dec 14, 2022
0
52
Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug ...
Dec 7, 2022
0
540
Should I get another booster? And if so, which vaccine should be used?
Dec 6, 2022
0
92
First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed "omicron" spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published ...
Dec 1, 2022
0
97
mRNA COVID-19 vaccines are less effective against omicron infections than other variants. A study published December 1 in the open access journal PLOS Medicine by Margaret L. Lind at the Yale School of Public Health and colleagues ...
Dec 1, 2022
0
43
Three currently circulating omicron subvariants of SARS-CoV-2—including two that currently make up almost 50% of reported COVID-19 infections in the U.S.—are better at evading vaccine- and infection-generated neutralizing ...
Nov 22, 2022
1
95
The total magnitude of the T-cell responses induced by mRNA and inactivated SARS-CoV-2 vaccines are comparable; however, the similarity ends here, according to a new study led by Duke-NUS Medical School scientists.
Oct 31, 2022
0
108
